Delivery Order SPE2DB20D1100-SPE2DB25FD7Y5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $23,364.42 to supply Skyrizi 150 mg/ml pen injections, with an ultimate completion date of August 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $12,962.95 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of SKYRIZI 150 mg/ml pen injections. This is a firm fixed-price contract with an ultimate completion date of July 28, 2025, and was competitively awarded with no set-aside designation. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999,999,999.00...
- The Defense Logistics Agency awarded a $18,136.65 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with an ultimate completion date of August 22, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $24,512.38 to AmerisourceBergen Drug Corp for the supply of Skyrizi 150 mg/mL pen injections. This competitively awarded, firm fixed-price contract was issued on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order with no set-aside designation, reflecting open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectors valued at $11,830. This competitively awarded, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of September 16, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $113,263.44 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of SKYRIZI 150 mg/mL pen injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation, with performance to be completed by August 8, 2025, at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,142.34 for SKYRIZI 150 mg/mL pen injectors on August 4, 2025, with completion scheduled for August 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $52,614.79 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/mL pen injectors. This firm fixed price delivery order, awarded on August 25, 2025, represents a non-set-aside competitive award with an ultimate completion date of August 26, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $11,830.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body injectors, with an ultimate completion date of September 9, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of SKYRIZI 150 mg/mL pen injectors, a pharmaceutical product used to treat inflammatory skin conditions. This firm fixed-price delivery order, valued at $15,523.25, represents a non-competitive set-aside award and is scheduled for completion by August 12, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD7Y5Delivery Order
The Defense Logistics Agency awarded a $32,614.21 delivery order to AmerisourceBergen Drug Corp for Skyrizi 150 mg/ml pen injectors on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems through the DLA Medical Supply Chain. The SPE2DX prime IDC serves as a global pharmaceutical support vehicle enabling the company to deliver specialty medications, brand-name and generic drugs, vaccines, and other medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This particular delivery order for Skyrizi, a specialized dermatological medication, exemplifies the company's role in fulfilling federal medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.6k | 8/1/25 |